1. Short title
This Act may be cited as the “Fair and Accurate Medicaid Pricing Act of 2019” or the “Fair AMP Act”.
Fair and Accurate Medicaid Pricing Act of 2019
A BILL
To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.
2. Excluding authorized generic drugs from calculation of average manufacturer price under the Medicaid drug rebate program; excluding manufacturers from definition of wholesaler
In general— Subparagraph (C) of section 1927(k)(1) of the Social Security Act (42 U.S.C. 1396r–8(k)(1)) is amended—
in the subparagraph heading, by striking “Inclusion” and inserting “Exclusion”;
by striking “a new drug application” and inserting “the manufacturer's new drug application”; and
by striking “inclusive” and inserting “exclusive”.
Excluding manufacturers from definition of wholesaler— Section 1927(k)(11) of the Social Security Act (42 U.S.C. 1396r–8(k)(11)) is amended—
by striking “manufacturers,”; and
by striking “manufacturer's and”.
Effective date— The amendments made by this section shall take effect on the first day of the first fiscal quarter that begins after the date of enactment of this Act.